Therefore, the positive correlation between the amount of monocytes, resting mast cells, and M2 macrophages and LRRC4C expression in patients with COAD and STAD suggests that LRRC4C is responsible for preserving immune-active status in the TME. Here, LRRC4C is linked to colon adenocarcinoma.